8-K
Current Report
Tarsus Pharmaceuticals, Inc. Filed Acc 0001193125-23-201717
Material agreement · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading d596862d8k.htm…